Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials

Taro Kishi, Tomohiko Mukai, Yuki Matsuda, Masatsugu Moriwaki, Nakao Iwata

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials'. Together they form a unique fingerprint.

Medicine & Life Sciences